Skip to main content
Log in

Monitoring Gold Plasma Levels in Rheumatoid Arthritis

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Bertrand, J.J.; Waine, H. and Tobias, C.A.: Distribution of gold in the animal body in relation to arthritis. Journal of Laboratory and Clinical Medicine 33: 1133–1138 (1948).

    PubMed  CAS  Google Scholar 

  • Blau, S.P.: Metabolism of gold during lactation. Arthritis and Rheumatism 16: 777–778 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Block, W.D.; Buchanan, O.H. and Freyberg, R.H.: Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. IV. Studies of the absorption, distribution and excretion of gold following the intramuscular injection of gold thioglucose and gold calcium thiomalate. Journal of Pharmacology and Experimental Therapeutics 76: 355–357 (1942).

    CAS  Google Scholar 

  • Cahill, R.N.P.: Effects of sodium aurothiomalate ‘Myochrysine’ on DNA synthesis in phytohemagglutinin-stimulated cultures of sheep lymphocytes. Experientia 27: 913–914 (1970).

    Article  Google Scholar 

  • Campion, D.S.; Olson, R.; Bohan, A. and Bluestone, R.: Interaction of gold sodium thiomalate (Myochrysine) with serum albumin. Journal of Rheumatology, Supplement 1 (Abstract) 1: 112 (1974).

    Google Scholar 

  • Cox, A.J. and Marich, K.W.: Gold in the dermis following gold therapy for rheumatoid arthritis. Archives of Dermatology 108: 655–657 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Empire Rheumatism Council Research Sub-committee: Gold therapy in rheumatoid arthritis: Report of a multi-centre controlled study. Annals of the Rheumatic Diseases 19: 95–117 (1960).

    Article  Google Scholar 

  • Empire Rheumatism Council Research Sub-committee: Gold therapy in rheumatoid arthritis: Final report of a multi-centre controlled trial. Annals of the Rheumatic Diseases 20: 315–333 (1961).

    Article  Google Scholar 

  • Freyberg, R.H.; Block, W.D. and Levy, S.: Metabolism, toxicity and manner of action of gold compounds used in treatment of arthritis: I. Human plasma and synovial fluid concentration and urinary excretion of gold during and following treatment with gold sodium thiomalate, gold sodium thiosulfate, and collodial gold sulfide. Journal of Clinical Investigation 20: 401–412 (1941).

    Article  PubMed  CAS  Google Scholar 

  • Gerber, R.C.; Paulus, H.E.; Bluestone, R. and Lederer, M.: Kinetics of aurothiomalate in serum and synovial fluid. Arthritis and Rheumatism 15: 625–629 (1972a).

    Article  PubMed  CAS  Google Scholar 

  • Gerber, R.C.; Paulus, H.E.; Bluestone, R. and Pearson, C.M.: Clinical response and serum gold levels in chrysotherapy. Lack of correlation. Annals of the Rheumatic Diseases 31: 308–310 (1972b).

    Article  CAS  Google Scholar 

  • Gerber, R.C.; Paulus, H.E.; Jennrich, R.I.; Lederer, M.; Bluestone, R.; Blahd, W.H. and Pearson, C.M.: Gold kinetics following aurothiomalate therapy: Use of a whole-body radiation counter. Journal of Laboratory and Clinical Medicine 83: 778–789 (1974).

    PubMed  CAS  Google Scholar 

  • Gottlieb, N.L.; Smith, P.M. and Smith, E.M.: Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis. Arthritis and Rheumatism 15: 582–592 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Gottlieb, N.L.; Smith, P.M. and Smith, E.M.: Pharmacodynamics of 197Au and 195Au labelled aurothiomalate in blood. Arthritis and Rheumatism 17: 171–183 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Gottlieb, N.L.; Kiem, I.M.; Penneys, N.S. and Schultz, D.R.: The influence of chrysotherapy on serum protein and immunoglobulin levels, rheumatoid factor, and antiepithelial antibody titers. Journal of Laboratory and Clinical Medicine 86: 962–972 (1975).

    PubMed  CAS  Google Scholar 

  • Grahame, R.; Billings, R.; Laurence, M.; Marks, V. and Wood, P.J.: Tissue gold levels after chrysotherapy. Annals of the Rheumatic Diseases 33: 536–539 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Harth, M.: Serum gold levels during chrysotherapy with relation to urinary and fecal excretion. Clinical Pharmacology and Therapeutics 15: 354–360 (1974).

    PubMed  CAS  Google Scholar 

  • Harth, M.; Stiller, C.; McGirr, D.; Evans, J. and Sinclair, N.: Effects of sodium aurothiomalate (SATM) on lymphocyte responses in normal man and patients with rheumatoid arthritis (RA). Abstract. Journal of Rheumatology 3: 100 (1976).

    Google Scholar 

  • Jeffrey, J.R.; Freundlich, H.F. and Bailey, D.M.: Distribution and excretion of radiogold in animals. Annals of the Rheumatic Diseases 17: 52–60 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Jessop, J.D. and Johns, R.G.S.: Serum gold determination in patients with rheumatoid arthritis receiving sodium aurothiomalate. Annals of the Rheumatic Diseases 32: 228–232 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Jessop, J.D.; Vernon-Roberts, B. and Harris, J.: Effects of gold salts and prednisolone on inflammatory cells. Annals of the Rheumatic Diseases 32: 294–300 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Jones, R.A.; Ahmed, M.W. and Chan, B.W.B.: Gold excretion in rheumatoid arthritis. British Medical Journal 1: 610 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Krusius, F.E.; Markkanen, A. and Peltola, P.: Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases 29: 232–235 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Lawrence, J.S.: Studies with radioactive gold. Annals of the Rheumatic Diseases 20: 341–352 (1961)

    Article  PubMed  CAS  Google Scholar 

  • Levy, G.: Kinetics of pharmacologic effects. Clinical Pharmacology and Therapeutics 7: 362–372 (1966).

    PubMed  CAS  Google Scholar 

  • Lorber, A.: Pharmacological application of chrysotherapy: Inhibitory effect on acid hydrolase activity of synovial fluid. Arthritis and Rheumatism 11: 495 (1968) (Abstract).

    Google Scholar 

  • Lorber, A.; Cohen, R.L.; Chang, C.C. and Anderson, H.E.: Gold determination in biological fluids by atomic absorption spectrophotometry: Application to chrysotherapy in rheumatoid arthritis patients. Arthritis and Rheumatism 11: 170–177 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Lorber, A.; Bovy, R.A. and Chang, C.C.: Relationship between serum gold content and distribution to serum immunoglobulins and complement. Nature New Biology 236: 250–252 (1972).

    Article  CAS  Google Scholar 

  • Lorber, A.; Atkins, C.J.; Chang, C.C.; Lee, Y.B.; Starrs, J. and Boyy, R.A.: Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis. Annals of the Rheumatic Diseases 32: 133–139 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Lorber, A.; Chandor, S.B.; Simon, T.M.; Leeb, J. and Carroll, Jr., P.E.: Immunosuppressive action of gold salts in rheumatoid arthritis. Journal of Rheumatology (Abstract) Supplement 1, 1:112 (1974).

    Google Scholar 

  • Lorber, A.; Simon, T.M.; Leeb, J. and Carroll, P.E.: Chrysotherapy: Pharmacological and clinical correlates. Journal of Rheumatology 2: 401–410 (1975).

    PubMed  CAS  Google Scholar 

  • Lorber, A.: Pharmacokinetics and effector availability of gold compounds; in Sutton (Ed) Gold Therapy in Arthritis (Marcel Dekker, New York, in Press 1977a).

  • Lorber, A.; Simon, T. and Wilcox, S.: In vivo gold kinetics —lymphocyte binding and effect on lymphocyte responsiveness. Arthritis and Rheumatism 20: 126 (1977b).

    Google Scholar 

  • Mascarenhas, B.R.; Granda, J.L. and Freyberg, R.H.: Gold metabolism in patients with rheumatoid arthritis treated with gold compounds — reinvestigated. Arthritis and Rheumatism 15: 391–402 (1972).

    Article  PubMed  CAS  Google Scholar 

  • McQueen, E.G. and Dykes, P.W.: Transport of gold in the body. Annals of the Rheumatic Diseases 28: 437–442 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Mohr, W.; Hersener, J. and Richter, R.: The localization of gold in the joints of patients with rheumatoid arthritis after chrysotherapy. Zeitschriff fur Rheumatologie 33: 369–375 (1974).

    Google Scholar 

  • Norton, W.L.; Lewis, D.C. and Ziff, M.: Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid. Arthritis and Rheumatism 11: 436–443 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Rubinstein, H.M. and Dietz, A.A.: Serum gold. II. Levels in rheumatoid-arthritis. Annals of the- Rheumatic Diseases 32: 128–132 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Smith, R.T.; Peak, W.T.; Kron, K.M.; Hermann, I.F.; DelToro, R.A. and Goldman, M.: Increasing the effectiveness of gold therapy in rheumatoid arthritis. Journal of the American Medical Association 167: 1197–1204 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Smith, P.M.; Smith, E.M. and Gottlieb, N.L.: Gold distribution in whole blood during chrysotherapy. Journal of Laboratory and Clinical Medicine 82: 930–937 (1973).

    PubMed  CAS  Google Scholar 

  • Solvsten, S.: Determination of gold in serum and urine by neutron activation analysis. Scandinavian Journal of Clinical and Laboratory Investigation 16: 39–44 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Withey, R.J.: Bioavailability and therapeutic efficacy. Revue Canadienne de Biologie 32: 21–30 (1973).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lorber, A. Monitoring Gold Plasma Levels in Rheumatoid Arthritis. Clin Pharmacokinet 2, 127–146 (1977). https://doi.org/10.2165/00003088-197702020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-197702020-00004

Keywords

Navigation